ReviewCancers2024

Adjuvant Therapy for High-Risk Stage II Melanoma: Current Paradigms in Management and Future Directions.

Gracia Maria Vargas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.